Methylphenidate extended-release orally disintegrating tablets (Cotempla XR-ODT™) in attention-deficit hyperactivity disorder in children aged 6–17 years: a profile of their use Katherine A. Lyseng-Williamson Adis Drug Q&A 29 November 2017 Pages: 43 - 49
SB4 (Benepali®; an etanercept biosimilar): a profile of its use Katherine A. Lyseng-WilliamsonKate McKeage Adis Drug Q&A 08 December 2017 Pages: 50 - 61
Routine maternal immunization against seasonal influenza, pertussis and tetanus protects the mother, fetus and young infant Adis Medical Writers Disease Management 28 December 2017 Pages: 62 - 66
Use acid-suppressing drugs appropriately with an individualized approach to minimize the risk of infection Adis Medical Writers Drug Reactions and Interactions 27 December 2017 Pages: 67 - 72
First reports of adverse drug reactions Drug Reactions and Interactions 26 December 2017 Pages: 73 - 74
Properly apply broad-spectrum sunscreens to maximize their photoprotective effects Adis Medical Writers Practical Issues and Updates 07 November 2017 Pages: 75 - 80
Ascorbic acid: still controversial when used against cancer resistance? Muhammad Torequl Islam Current Opinion 29 December 2017 Pages: 81 - 84
From pharmacy faculty to pharmacy shop: still a logical pathway in Europe? Livio GarattiniAnna Padula Commentary 26 December 2017 Pages: 85 - 88